R&D Investment
First written in FY2017-Q1. 8 of 35 entries say "Restated". Latest entry: FY2026.
91 other companies' latest entry also says "Other".
- FY2026Annual R&D expenses increasedAnnual report
「R&D expenses incurred during the consolidated fiscal year were ¥581 million.」
Annual R&D expenses were ¥581 million, up from ¥488 million in the previous fiscal year. - FY2026-H1RestatedAnnual report
「Total R&D expenses for the current interim consolidated period were ¥293 million.」
The total R&D expenses for the interim consolidated period continue to be disclosed. - FY2025Annual R&D expenses decreased slightlyAnnual report
「R&D expenses incurred during the consolidated fiscal year were ¥488 million.」
Annual R&D expenses were ¥488 million, down slightly from ¥489 million in the previous fiscal year. - FY2024Annual R&D expenses increasedAnnual report
「R&D expenses incurred during the consolidated fiscal year were ¥489 million.」
Annual R&D expenses were ¥489 million, up from ¥474 million in the previous fiscal year. - FY2024-Q3Cumulative third-quarter R&D expenses increasedAnnual report
「Total R&D expenses for the nine-month consolidated period were ¥360 million.」
R&D expenses for the nine-month period were ¥360 million, up from ¥350 million in the same period of the previous year. - FY2024-Q2First-half R&D expenses decreasedAnnual report
「Total R&D expenses for the six-month consolidated period were ¥237 million.」
First-half R&D expenses were ¥237 million, down from ¥247 million in the same period of the previous year. - FY2024-Q1Quarterly R&D expenses decreasedAnnual report
「Total R&D expenses for the three-month consolidated period were ¥118 million.」
Quarterly R&D expenses were ¥118 million, down from ¥123 million in the same period of the previous year. - FY2023Annual R&D expenses decreasedAnnual report
「R&D expenses incurred during the consolidated fiscal year were ¥474 million.」
Annual R&D expenses were ¥474 million, down from ¥485 million in the previous fiscal year. - FY2023-Q3Nine-month R&D expenses decreasedAnnual report
「Total R&D expenses for the nine-month consolidated period were ¥350 million.」
R&D expenses for the nine-month period were ¥350 million, down from ¥367 million in the same period of the previous year. - FY2023-Q2First-half R&D expenses increased slightlyAnnual report
「Total R&D expenses for the six-month consolidated period were ¥247 million.」
First-half R&D expenses were ¥247 million, a slight increase from ¥244 million in the same period of the previous year. - FY2023-Q1Quarterly R&D expenses increased slightlyAnnual report
「Total R&D expenses for the three-month consolidated period were ¥123 million.」
Quarterly R&D expenses were ¥123 million, a slight increase from ¥122 million in the same period of the previous year. - FY2022Annual R&D expenses fell significantlyAnnual report
「R&D expenses incurred during the consolidated fiscal year were ¥485 million.」
Annual R&D expenses were ¥485 million, down from ¥754.478 million in the previous fiscal year. - FY2022-Q3Nine-month R&D expenses decreasedAnnual report
「Total R&D expenses for the nine-month consolidated period were ¥367 million.」
R&D expenses for the nine-month period were ¥367 million, down from ¥556 million in the same period of the previous year. - FY2022-Q2First-half R&D expenses decreasedAnnual report
「Total R&D expenses for the six-month consolidated period were ¥244 million.」
First-half R&D expenses were ¥244 million, down from ¥360 million in the same period of the previous year. - FY2022-Q1Quarterly R&D expenses decreasedAnnual report
「Total R&D expenses for the three-month consolidated period were ¥122 million.」
Quarterly R&D expenses were ¥122 million, down from ¥159 million in the same period of the previous year. - FY2021Annual R&D expenses decreasedAnnual report
「R&D expenses incurred during the consolidated fiscal year were ¥754 million.」
Annual R&D expenses were ¥754 million, down from ¥821 million in the previous fiscal year. - FY2021-Q3Nine-month R&D expenses decreasedAnnual report
「Total R&D expenses for the nine-month consolidated period were ¥556 million.」
R&D expenses for the nine-month period were ¥556 million, down from ¥622 million in the same period of the previous year. - FY2021-Q2First-half R&D expenses decreasedAnnual report
「Total R&D expenses for the six-month consolidated period were ¥360 million.」
First-half R&D expenses were ¥360 million, down from ¥409 million in the same period of the previous year. - FY2021-Q1Quarterly R&D expenses decreasedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥159 million.」
Quarterly research and development expenses amounted to ¥159 million, down from ¥208 million in the same period of the previous year. - FY2020Annual R&D expenses increasedAnnual report
「Research and development expenses incurred during the current consolidated fiscal year amounted to ¥821 million.」
Annual research and development expenses amounted to ¥821 million, up from ¥817 million in the previous fiscal year. - FY2020-Q3Cumulative third-quarter R&D expenses increasedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥622 million.」
Cumulative third-quarter research and development expenses amounted to ¥622 million, up from ¥618 million in the same period of the previous year. - FY2020-Q2Half-year research and development expenses increasedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥414 million.」
The company continued to disclose cumulative quarterly research and development expenses, which increased from ¥409 million in the same period of the previous year to ¥414 million. - FY2020-Q1Increase in quarterly R&D expensesAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥208 million.」
Research and development expenses amounted to ¥208 million, up from ¥203 million in the same period of the previous year. - FY2019Annual R&D expenses increasedAnnual report
「Research and development expenses incurred during the current consolidated fiscal year amounted to ¥817 million.」
Annual research and development expenses amounted to ¥817 million, up from ¥808 million in the previous fiscal year. - FY2019-Q3Cumulative third-quarter research and development expenses increasedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥618 million.」
Cumulative third-quarter research and development expenses amounted to ¥618 million, up from ¥603 million in the same period of the previous year. - FY2019-Q2Half-year research and development expenses increasedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥409 million.」
The company continued to disclose cumulative quarterly research and development expenses, which increased from ¥400 million in the same period of the previous year to ¥409 million. - FY2019-Q1Increase in quarterly R&D expensesAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥215 million.」
The company continued to disclose cumulative quarterly research and development expenses, which increased from ¥203 million in the same period of the previous year to ¥215 million. - FY2018RestatedAnnual report
「Research and development expenses incurred during the current consolidated fiscal year amounted to ¥808 million.」
The company continued to disclose total research and development expenses for the fiscal year. The figure increased from ¥787 million in the previous fiscal year. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥603 million.」
The company continued to disclose cumulative quarterly research and development expenses. - FY2018-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥400 million.」
The company continued to disclose cumulative quarterly research and development expenses. - FY2018-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥203 million.」
The company continued to disclose cumulative quarterly research and development expenses. No significant change in the content from the ¥202 million recorded in the same period of the previous year was stated. - FY2017RestatedAnnual report
「Research and development expenses incurred during the current consolidated fiscal year amounted to ¥787 million.」
The company disclosed total research and development expenses for the fiscal year. This is the annual figure following the disclosure of cumulative quarterly research and development expenses. - FY2017-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥589 million.」
The company disclosed total research and development expenses for the cumulative third quarter. - FY2017-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥397 million.」
The company disclosed total research and development expenses for the cumulative second quarter. - FY2017-Q1First statedAnnual report
「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥202 million.」
The company disclosed total research and development expenses for the first quarter.